Induction of Short-Term Remission With Single Agent Eltrombopag in Refractory Nucleophosmin-1-Mutated Acute Myeloid Leukemia

Haematologica - Italy
doi 10.3324/haematol.2014.111948
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Nucleophosmin Mutations in Acute Myeloid Leukemia in Children

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Spontaneous Remission of Acute Myeloid Leukemia – A Single Center Case Reports

Klinicka Onkologie
Oncology
2013English

Imidazoquinoxaline Derivative EAPB0503: A Promising Drug Targeting Mutant Nucleophosmin 1 in Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2017English

Remission to Transplantation Time in Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Optimizing Survival Outcomes With Post‐remission Therapy in Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2019English

Comparison of Clinical Remission and Survival Between CLAG and FLAG Induction Chemotherapy in Patients With Refractory or Relapsed Acute Myeloid Leukemia: A Prospective Cohort Study

Clinical and Translational Oncology
MedicineCancer ResearchOncology
2017English

Kinetics of Bone Marrow Blasts During Induction and Achievement of Complete Remission in Acute Myeloid Leukemia

Haematologica
Hematology
2008English

DNA Damage Corrects the Aberrant Cytoplasmic Localisation of Nucleophosmin in NPM1 Mutated Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2019English

Acute Myeloid Leukemia With Mutated NPM1 Demonstrating Multilineage Dysplasia and Marked Thrombocytosis

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy